Central neurocytoma is a rare, slow-growing and low-grade tumor of the brain that arises from the cells of the cerebrum. It is thought to originate from the cells of the central nervous system, and is most common in people between the ages of 20 and 40.
Central neurocytoma is usually diagnosed through imaging tests such as magnetic resonance imaging (MRI) or computerized tomography (CT) scans. These tests can help to detect any abnormality in the structure or size of the brain and can also provide information about the size and location of the tumor.
Other brain tumors, such as glioblastoma, meningioma, and astrocytoma, should be considered in the differential diagnosis of central neurocytoma.
Treatment options for central neurocytoma depend on the size and location of the tumor. Surgery is the primary treatment option and is usually successful in removing the tumor. Radiation therapy may be used in some cases in order to reduce the size of the tumor before surgery.
The prognosis for central neurocytoma is generally good, with most tumors responding well to treatment. However, in some cases, the tumor may recur, and further treatment may be necessary.